Check-Cap Ltd. logo

Check-Cap Ltd. (CHEK)

Market Closed
21 May, 20:00
NASDAQ (CM) NASDAQ (CM)
$
1. 86
+0.03
+1.6393%
$
10.88M Market Cap
- P/E Ratio
- Div Yield
39,365 Volume
-3.25 Eps
$ 1.83
Previous Close
Investors:
Add Transaction
Day Range
1.77 1.86
Year Range
0.56 3.13
Want to track CHEK and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

CHEK closed Thursday higher at $1.86, an increase of 1.6393% from Wednesday's close, completing a monthly increase of 44.186% or $0.57. Over the past 12 months, CHEK stock gained 17.7215%.
CHEK is not paying dividends to its shareholders.
The last earnings report, released on Feb 25, 2026, exceeded the consensus estimates by 0%. On average, the company has surpassed earnings expectations by 0%, based on the last three reports.
Check-Cap Ltd. has completed 2 stock splits, with the recent split occurring on Nov 25, 2022.
The company's stock is traded on one exchange.

CHEK Chart

People also search for

CVV
CVD Equipment Corporation
$ 6.51
+4.3269%
Fuel Tech Inc.
$ 1.44
+4.3478%
SEP Acquisition Corp.
$ -
-
Rising Dragon Acquisition Corp.
$ 6
-7.5408%
MicroAlgo Inc.
$ 4.05
+2.6616%

Check-Cap Ltd. Investors

Name Quantity Cost Value Profit ($) Gain (%)
ABB
Alexander Bjornager Bonde Danske Bank A/S
1 $1.26 $1.86 $0.6 47.62%
Hui Fai Tam
Hui Fai Tam Caitong International Asset Management Co. Ltd.
2 $3.22 $2 -$1.22 -37.89%
AFI
Aviso Financial Inc. Aviso Financial Inc.
100 $212 $186 -$26 -12.26%

Check-Cap Ltd. (CHEK) FAQ

What is the stock price today?

The current price is $1.86.

On which exchange is it traded?

Check-Cap Ltd. is listed on NASDAQ (CM).

What is its stock symbol?

The ticker symbol is CHEK.

Does it pay dividends? What is the current yield?

It does not pay dividends to its shareholders.

What is its market cap?

As of today, the market cap is 10.88M.

Has Check-Cap Ltd. ever had a stock split?

Check-Cap Ltd. had 2 splits and the recent split was on Nov 25, 2022.

Check-Cap Ltd. Profile

Professional Services Industry
Industrials Sector
David Lontini CEO
NASDAQ (CM) Exchange
M2361E203 CUSIP
IL Country
85 Employees
- Last Dividend
25 Nov 2022 Last Split
19 Feb 2015 IPO Date

Overview

Check-Cap Ltd. stands as a pioneering entity in the medical diagnostics industry, specifically focusing on the development of innovative, non-invasive screening technologies. Based in Isfiya, Israel, and established in 2004, the company dedicates its efforts to the clinical stage advancement of a unique capsule-based system. This technology employs ultra-low-dose X-rays to meticulously scan the colon's inner lining for precancerous polyps and other structural abnormalities. This approach marks a significant stride toward early detection and prevention of colorectal cancer, aligning with the global need for more accessible and less invasive screening methods.

Products and Services

Check-Cap Ltd.'s product portfolio is centered around the C-Scan system, a ground-breaking advancement in the field of colorectal cancer screening. The C-Scan system comprises:

  • C-Scan Cap: This is the core of the screening technology – an ingestible, capsule-based device designed to perform an X-ray scan of the colon. Engineered for comfort and safety, the C-Scan Cap navigates through the gastrointestinal tract, capturing high-resolution images to identify suspected polyps and other abnormalities. Its utilization of ultra-low-dose X-rays encapsulates a pivotal innovation in minimizing radiation exposure while ensuring diagnostic efficacy.
  • C-Scan Track: Complementing the C-Scan Cap, the C-Scan Track is a disposable tracking system that is securely attached to the patient's back. It employs biocompatible adhesive skin patches to stay in place throughout the procedure. This component is crucial for accurately monitoring the capsule's position within the colon, facilitating precise imaging and data collection. The non-invasiveness and patient-friendly design of the C-Scan Track underscore Check-Cap's commitment to enhancing the screening experience.
  • C-Scan View software: The technological ecosystem of the C-Scan system is completed by the C-Scan View software, a sophisticated client/server-based application. It plays a pivotal role in managing the screening process by enabling the procedure data download from the C-Scan Track, performing comprehensive data analysis, and generating detailed reports. This software embodies the integration of advanced computing in medical diagnostics, pushing the boundaries of accuracy, and efficiency in colorectal cancer screening.

Contact Information

Address: Check-Cap Building
Phone: 972 4 830 3401